Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of IgA Nephropathy Causal Factors in Plasma Proteins, Immune Cell Types, and Immune Cell Traits. | Clin J Am Soc Nephrol | 2026 | 41811388 | PubTator, text mining | PubMed |
| Identification of MTURN as a trained immunity-related biomarker for heart failure via integrative transcriptomic machine learning analysis and experimental validation. | Front Immunol | 2026 | 41789108 | PubTator, text mining | PubMed |
| From post-infectious glomerulonephritis to complement-mediated aHUS: a diagnostic challenge. | Pediatr Nephrol | 2026 | 41784797 | PubTator, text mining | PubMed |
| C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies. | Kidney Med | 2026 | 41783430 | PubTator, text mining | PubMed |
| Primary membranoproliferative glomerulonephritis: natural history, pathogenesis, and treatment. | Front Nephrol | 2026 | 41767602 | PubTator, text mining | PubMed |
| Gene Therapy Advancements in Age-Related Macular Degeneration Treatment. | Cells | 2026 | 41744818 | PubTator, text mining | PubMed |
| Forecasting left ventricular systolic dysfunction in heart failure with artificial intelligence. | EClinicalMedicine | 2026 | 41717586 | PubTator, text mining | PubMed |
| Proteomic Signature in Men with Central Serous Chorioretinopathy. | J Proteome Res | 2026 | 41641862 | PubTator, text mining | PubMed |
| The CFH-CFHR5 Locus in Wet Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy, and Central Serous Chorioretinopathy. | Ophthalmol Sci | 2026 | 41626425 | PubTator, text mining | PubMed |
| Successful term pregnancy after renal transplant in end-stage renal disease with complement factor H-related mutation: A case report. | World J Transplant | 2026 | 41607808 | PubTator, text mining | PubMed |
| CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy. | J Am Soc Nephrol | 2026 | 41563799 | PubTator, text mining | PubMed |
| Dual Role of Factor H-Related Protein 1 in IgA Nephropathy Kidney Injury. | Kidney Int Rep | 2026 | 41541767 | PubTator, text mining | PubMed |
| Gut proteome and microbiome alterations: Analysis of transverse colon samples from pathologically confirmed Alzheimer's disease patients. | Alzheimers Dement | 2026 | 41527485 | PubTator, text mining | PubMed |
| Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca. | Med Pharm Rep | 2025 | 41496885 | PubTator, text mining | PubMed |
| The Impact of Complement Factor H-Related Protein Gene Deletions on Kidney Transplantation. | Scand J Immunol | 2025 | 41309447 | PubTator, text mining | PubMed |
| Complement proteins associated with circulatory and glomerular IgA-containing immune complexes in patients with IgA nephropathy. | Sci Rep | 2025 | 41298751 | PubTator, text mining | PubMed |
| Navigating Pediatric Atypical Hemolytic Uremic Syndrome: A Two-Year Case Series From Eastern India. | Cureus | 2025 | 41287690 | PubTator, text mining | PubMed |
| [Ultra-early administration of eculizumab in a child with atypical hemolytic uremic syndrome: a case report]. | Zhongguo Dang Dai Er Ke Za Zhi | 2025 | 41250542 | PubTator, text mining | PubMed |
| Identification of potential therapeutic targets for complement-associated glomerular diseases using Mendelian randomization. | Medicine (Baltimore) | 2025 | 41029142 | PubTator, text mining | PubMed |
| Carfilzomib-Associated Thrombotic Microangiopathy in a Multiple Myeloma Patient: Complement Genetic Alterations Impact and Eculizumab Therapy. | Cureus | 2025 | 40895697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=2